Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JunB proto-oncogene, AP-1 transcription factor subunit (JUNB), is a DNA-binding transcription factor belonging to the activator protein 1 (AP-1) complex, characterized by a basic leucine zipper (bZIP) domain for dimerization and DNA binding. It is encoded on chromosome 19p13 and regulates diverse physiological processes including placental and cardiovascular development, bone formation, epidermal homeostasis, as well as the differentiation and function of immune cells such as T cells, macrophages, dendritic cells, and neutrophils. JunB acts via the AP-1 complex, forming homodimers or heterodimers (frequently with Fos or BATF proteins) to regulate gene expression in response to external stimuli such as cytokines, stress, and growth factors. Dysregulation of JunB is implicated in several cancers, particularly myeloid leukemias where its loss is linked to enhanced proliferation and reduced differentiation of hematopoietic stem cells. JunB is also involved in the regulation of inflammatory responses and the tumor microenvironment. Restoration of JunB expression via epigenetic drugs has been investigated as a therapeutic strategy in certain leukemias[1][2].
Epigenetic modulation to restore JunB expression (histone deacetylase inhibition, DNA demethylation); Indirect restoration of differentiation and inhibition of proliferation (via AP-1 pathway modulation)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JunB proto-oncogene, AP-1 transcription factor subunit (JUNB).